Metabolic-Dysfunction Associated Fatty Liver Disease (MAFLD)
Confidently diagnose and manage MAFLD in T2DM patients
Metabolic-associated fatty liver disease (MAFLD) is a rapidly growing health concern globally and in Australia.
Strongly linked with type 2 diabetes and cardiometabolic conditions, it presents a complex challenge for
specialists managing metabolic disease.
Why enrol
Despite its prevalence, MAFLD remains underdiagnosed and inconsistently managed in specialist practice.
This course addresses key clinical gaps by providing practical, evidence-based strategies to improve
detection, risk stratification and management in patients with type 2 diabetes.
What you'll learn
Through case-based learning, participants will develop skills in identifying high-risk individuals,
assessing fibrosis risk, and implementing systematic management approaches aligned with current guidelines.
Course highlights
- Self-paced, flexible learning format
- Case-based clinical scenarios
- Evidence-based guidance and resources
- Short, focused modules designed for specialists
- Immediate application to clinical practice
Who should attend
This course is designed for endocrinologists and physicians with an interest in metabolic disease who are
involved in the management of patients with type 2 diabetes.
Strengthen your clinical approach to MAFLD and improve patient outcomes through this targeted,
specialist-level education.
Topics
- MAFLD overview and epidemiology
- MAFLD in type 2 diabetes
- Screening and diagnosis
- Risk stratification and fibrosis assessment
- Clinical management approaches
- Monitoring and long-term care
- Referral pathways to hepatology
Learning outcomes
Participants will be able to:
- Identify individuals at high risk of MAFLD
- Assess risk of advanced liver fibrosis
- Apply systematic approaches to metabolic optimisation
- Recommend appropriate medical management strategies
- Refer patients appropriately to specialist services
Course delivery method
This course is online, asynchronous and delivered in self-paced modules via Canvas.
It includes recorded lectures, case-based learning, and multiple-choice questions with
feedback (non-assessed learning).
Course pre-requisites
Registered specialist medical practitioner (AHPRA)
Additional Information
Accreditation:
AMA CPD endorsement
RACP self-reported CPD eligible
Australian Diabetes Society endorsement
Participants must successfully complete at least 80% of the program content to be eligible
for completion recognition. Progression through the content will be tracked, and participants
will be required to submit a self-declaration at the conclusion of the program confirming
that this completion threshold has been met.
Upon successful completion of the program, participants will be issued with a Certificate
of Completion from the University of Sydney.
This program is developed and delivered as part of an Independent Medical Education Grant
sponsored by Eli Lilly. The University of Sydney has full editorial control of the material taught.
For terms and conditions, please view
here
.
| Course fees |
| Standard |
Free |
|
|